Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Upperton Wins Pharma Project of the Year at 2024 Pharma Industry Awards UK

by
September 25, 2024
in Economy, Investing
0
Upperton Wins Pharma Project of the Year at 2024 Pharma Industry Awards UK
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Last Updated on:

Upperton Pharma Solutions has been awarded the Pharma Project of the Year at the Pharma Industry Awards UK 2024, held at Birmingham’s International Convention Centre (ICC) on Wednesday, 18th September. The event recognised excellence across the pharmaceutical and biotech sectors, celebrating achievements in a range of categories.

Upperton triumphed over competitors Sanofi and Bouygues Energies & Services for its exceptional work on the 50,000-square-foot Trent Gateway facility, which was noted for its outstanding project management, strategic collaboration with UK-based suppliers, and swift delivery, taking just 10 months to complete.

The Trent Gateway facility represents a major expansion for Upperton, incorporating 10 GMP manufacturing suites alongside quality control laboratories, formulation development labs, analytical labs, and pilot plant spaces. This state-of-the-art facility enhances Upperton’s ability to meet rising client demand and further advance its services in pharmaceutical development.

Ian Lafferty, Chief Technical Officer and Project Lead for Trent Gateway, praised the team’s dedication: “This award is the culmination of 18 months of hard work by our team. To build a facility of this quality within 10 months is an outstanding achievement. To then validate, commission and receive MHRA Approval provided us with a platform to develop and manufacture on a new scale for our customers.”

Nikki Whitfield, Upperton’s Chief Executive Officer, reflected on the achievement: “To be recognised for our Trent Gateway facility is an outstanding achievement. The state-of-the-art facility satisfies our increasing customer demand and extends our service offering further along the drug development pathway. The facility meets our clients’ requirements from a complexity, scale, and potency perspective, whilst adhering to all the necessary regulatory requirements. The dedication and attention to detail by our team have allowed us to elevate our services while working with the best talent in the Midlands and the wider sector. This facility is a testament to our commitment to growth and innovation.”

The Pharma Project of the Year award highlights Upperton’s innovative approach to working with UK supply chains and delivering cutting-edge pharmaceutical development and manufacturing solutions.

Trent Gateway is designed to support the development and production of various dosage forms, including oral solids, liquids, semi-solids, nasal, and inhaled products. The facility facilitates early-stage formulation and offers clinical trial supplies from Phase 1 to Phase 3. Its GMP infrastructure, state-of-the-art equipment, and containment capabilities allow it to handle batch sizes of up to 250kg, supporting larger-scale manufacturing operations.

ShareTweetPin

Related Posts

Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats Arizona Robotics Hub
Investing

Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats Arizona Robotics Hub

June 22, 2025
Editor’s Picks: Silver Price Hits 13 Year High, Gold Takes a Breather
Investing

Editor’s Picks: Silver Price Hits 13 Year High, Gold Takes a Breather

June 22, 2025
Crypto Market Recap: Bitcoin Price Stalls as Fed Holds Rates Steady, Circle Shares Jump
Investing

Crypto Market Recap: Bitcoin Price Stalls as Fed Holds Rates Steady, Circle Shares Jump

June 21, 2025
Top 5 Canadian Mining Stocks This Week: Royalties Inc. Jumps 183 Percent on Legal Win
Investing

Top 5 Canadian Mining Stocks This Week: Royalties Inc. Jumps 183 Percent on Legal Win

June 21, 2025
Critical Metals Secures US$120 Million Loan LOI for Tanbreez Rare Earths Project
Investing

Critical Metals Secures US$120 Million Loan LOI for Tanbreez Rare Earths Project

June 20, 2025
Mali Court Seizes Control of Barrick Gold Mine Amid Escalating Dispute
Investing

Mali Court Seizes Control of Barrick Gold Mine Amid Escalating Dispute

June 20, 2025
Next Post
Royal jeweller cuts prices by 20% to counter impact of tourist tax

Royal jeweller cuts prices by 20% to counter impact of tourist tax

Recommended

Dave Antrobus Considers AI’s Role in Combating Climate Change in the UK: Innovations & Challenges

Dave Antrobus Considers AI’s Role in Combating Climate Change in the UK: Innovations & Challenges

September 19, 2024
Potato Corner hits 2,000th store

Potato Corner hits 2,000th store

September 19, 2024
MTRCB sets new record for materials reviewed

MTRCB sets new record for materials reviewed

January 2, 2025
August infrastructure spending declines 11%

August infrastructure spending declines 11%

October 29, 2024
VP Sara resignation sought

VP Sara resignation sought

September 24, 2024
Bridging the Gap: The Bataan-Cavite Interlink Bridge

Bridging the Gap: The Bataan-Cavite Interlink Bridge

September 8, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved